MedPath

Irrigating vs Traditional Negative Pressure Wound Therapy to Treat Necrotizing Soft Tissue Infections

Not Applicable
Not yet recruiting
Conditions
Necrotizing Soft Tissue Infections
Registration Number
NCT07120386
Lead Sponsor
HealthPartners Institute
Brief Summary

Necrotizing Soft Tissue Infections (NSTIs) are rapidly progressing infections that have a high morbidity and mortality, with the greatest morbidity related to managing the large wounds required to treat these patients. Initial treatment requires wide surgical removal of infected tissue and optimal management is essential to reducing morbidity in these patients. Negative pressure wound therapy (NPWT) is a widely used technology that has revolutionized wound management. NPWT is utilized across the spectrum of acute wounds, including routine postoperative incision management, traumatic wounds, and wounds related to surgical debridement of NSTIs which are frequently some of the most complicated of wounds encountered. Most NSTI cases at Regions Hospital currently utilize negative pressure wound therapy with instillation (NPWTi) where the wound is irrigated to clean out debris. Currently, there is a paucity of data comparing traditional NPWT and NPWTi and the choice of which device to use is left to surgeon discretion. This study is a first step at identifying the effects of NPWTi compared to NPWT alone on the care of NSTI patients. If the theoretical benefits of NPWTi over NPWT translate to practice, those treated with NPWTi would be expected to have a reduced rate of hospital readmission after their index hospitalization in addition to shorter time to definitive closure/coverage. This is a pilot study to assess the feasibility of enrolling patients with NSTIs in a randomized controlled trial to assess outcomes between the two devices.

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
30
Inclusion Criteria
  • Clinical suspicion for Necrotizing Soft Tissue Infection (NSTI) necessitating emergent operative intervention
  • Age >/=18 years old
  • Planned application of a negative pressure wound dressing
Exclusion Criteria
  • Patients who have a wound that does not allow for a wound vac
  • Patients receiving acute treatment for a NSTI at another institution
  • Incarcerated patients
  • Patients who do not survive to wound closure/coverage
  • Patients <18 years old

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Unplanned hospital readmissionWithin 30 days of discharge

Did the patient have an unplanned readmission to the hospital (Y/N) within 30 days of discharge

Rate of healingFirst operation and last operation

Time from index debridement to final coverage in days

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Regions Hospital

🇺🇸

Saint Paul, Minnesota, United States

Regions Hospital
🇺🇸Saint Paul, Minnesota, United States
Nicholas J Larson
Contact
651-254-4846
RegionsSurgicalResearch@HealthPartners.com
Brian S Myer, MD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.